Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for chronic post-chikungunya joint pain
RBR-6mkndkPhase 2Not yet recruiting
- Sponsor
- Rodrigo Souza Rodrigues
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pregabalin in Chikungunya (CHIKV) and Post-chikungunya arthralgia (PCA) (2 arms), sponsored by Rodrigo Souza Rodrigues. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
Chikungunya (CHIKV)Post-chikungunya arthralgia (PCA)
Beyond the preview
Go deeper on RBR-6mkndk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6mkndk.